CA2215382A1 - Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women - Google Patents

Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women Download PDF

Info

Publication number
CA2215382A1
CA2215382A1 CA002215382A CA2215382A CA2215382A1 CA 2215382 A1 CA2215382 A1 CA 2215382A1 CA 002215382 A CA002215382 A CA 002215382A CA 2215382 A CA2215382 A CA 2215382A CA 2215382 A1 CA2215382 A1 CA 2215382A1
Authority
CA
Canada
Prior art keywords
estradiol
once
month
perimenopausal
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002215382A
Other languages
English (en)
French (fr)
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2215382A1 publication Critical patent/CA2215382A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
CA002215382A 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women Abandoned CA2215382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861.2 1995-03-16
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen

Publications (1)

Publication Number Publication Date
CA2215382A1 true CA2215382A1 (en) 1996-09-19

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002215382A Abandoned CA2215382A1 (en) 1995-03-16 1996-03-15 Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women

Country Status (17)

Country Link
EP (1) EP0814811A1 (no)
JP (1) JPH11501649A (no)
KR (1) KR19980703058A (no)
AR (1) AR002283A1 (no)
AU (1) AU713258B2 (no)
CA (1) CA2215382A1 (no)
CZ (1) CZ289697A3 (no)
DE (1) DE19510861A1 (no)
HU (1) HUP9801691A3 (no)
IL (1) IL117516A (no)
MX (1) MX9707009A (no)
NO (1) NO974255L (no)
NZ (1) NZ304027A (no)
PL (1) PL322202A1 (no)
SK (1) SK123997A3 (no)
WO (1) WO1996028165A1 (no)
ZA (1) ZA962177B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
IL117516A (en) 2000-07-26
NZ304027A (en) 2000-05-26
MX9707009A (es) 1997-11-29
NO974255L (no) 1997-11-14
AU5110896A (en) 1996-10-02
AU713258B2 (en) 1999-11-25
HUP9801691A2 (hu) 1998-11-30
AR002283A1 (es) 1998-03-11
EP0814811A1 (de) 1998-01-07
WO1996028165A1 (de) 1996-09-19
CZ289697A3 (en) 1997-12-17
DE19510861A1 (de) 1996-09-19
JPH11501649A (ja) 1999-02-09
SK123997A3 (en) 1998-02-04
ZA962177B (en) 1996-07-29
IL117516A0 (en) 1996-07-23
NO974255D0 (no) 1997-09-15
PL322202A1 (en) 1998-01-19
KR19980703058A (ko) 1998-09-05
HUP9801691A3 (en) 1999-03-01

Similar Documents

Publication Publication Date Title
RU2189819C2 (ru) Схемы приема прогестогена-антипрогестогена
US20090005351A1 (en) Hormone replacement therapy
HU221169B1 (en) Use of estrogen and antiprogestin for producing pharmaceutical compositions useful in hormon replacement therapy and kit containing the same
HU223753B1 (hu) Természetes ösztrogén bázisú többlépcsős fogamzásgátló készítmény
FI117850B (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
AU2001250034A1 (en) Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
US6506390B2 (en) Progestogen-anti-progestogen regimens
AU2005237255A1 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
JP2000502108A (ja) ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット
JP2007511533A (ja) 段階的エストロゲン避妊薬
AU2005235418C1 (en) Multi-phase contraceptive preparation based on a natural estrogen
US20090137537A1 (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
IL177475A (en) Use of progestogen and an estrogen for the manufacture of a multiphasic contraception medicament, a multiphase combination and contraceptive kit
BG62877B1 (bg) Метод за контрол на женски фертилитет
US20010006963A1 (en) Once-a-month injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
JP2942560B2 (ja) エストロゲン欠乏症治療用組成物
JP2005530791A (ja) 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法
AU713258B2 (en) Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
US20030176404A1 (en) Progestogen-anti-progestogen regimens
WO2021260511A1 (en) Multiphasic contraceptive and/or hormone replacement therapy
EP1007052A1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
JP2005530790A (ja) 閉経後の障害を治療するためのトリメゲストンおよびエストロゲン
JP2005527574A (ja) ホルモン補充療法におけるトリメゲストンと組み合わせた結合型エストロゲンの使用
JP2005527577A (ja) ホルモン補充療法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued